Last update 21 Nov 2024

CD19+CXCR5 cells (Guangzhou Bio-gene Technology )

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
CD19 x CXCR5
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CXCR5 antagonists(C-X-C motif chemokine receptor 5 antagonists)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Hematologic Neoplasms
Inactive Indication-
Originator Organization
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
Active Organization
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CD19+CXCR5 cells (Guangzhou Bio-gene Technology )
ChiCTR2100052677 / RecruitingEarly Phase 1IIT
Single-Center, single-arm, non-blind safety and effectiveness clinical study of improved CAR-T cell therapy for B-cell lymphoma
100 Clinical Results associated with CD19+CXCR5 cells (Guangzhou Bio-gene Technology )
Login to view more data
100 Translational Medicine associated with CD19+CXCR5 cells (Guangzhou Bio-gene Technology )
Login to view more data
100 Patents (Medical) associated with CD19+CXCR5 cells (Guangzhou Bio-gene Technology )
Login to view more data
1
Literatures (Medical) associated with CD19+CXCR5 cells (Guangzhou Bio-gene Technology )
27 Sep 2024Current Cancer Drug Targets
Phase I Clinical Trial of CD19 CAR-T Cells Expressing CXCR5 Protein for the Treatment of Relapsed or Refractory B-cell Lymphoma
100 Deals associated with CD19+CXCR5 cells (Guangzhou Bio-gene Technology )
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hematologic NeoplasmsPhase 1-
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free